Attention Planning Editors: Xi'an Qujiang Film and TV Investment Group to Announce First U.S. Film Investment in Hollywood Ceremony
May 12, 2011 12:19 ET
|
QFTV
LOS ANGELES, CA--(Marketwire - May 12, 2011) - Marking one of the largest Chinese-based investments in a film production ever, the Qujiang Film and TV Investment Group, based in Xi'an, China, will...
Proposed Sale and Leaseback of 11 State of California Office Buildings Shorts Taxpayers $2 Billion Compared to QueensFort Capital's Bid
September 09, 2010 10:00 ET
|
QueensFort Capital Corporation
SAN FRANCISCO, CA--(Marketwire - September 9, 2010) - Citing California's projected 2010-2011 budget deficit of over $20 billion, QueensFort Capital Corporation today detailed the shortfall...
MEDIA ADVISORY: Angeles Chorale Presents "America -- Our Music, Our Heritage"
March 09, 2010 15:58 ET
|
Angeles Chorale
LOS ANGELES, CA--(Marketwire - March 9, 2010) - Los Angeles's own Angeles Chorale, the
Passionate Voice of Los Angeles, will hold its annual spring concert at the
First United Methodist Church in...
The Angeles Chorale to Perform Handel's "Messiah" on December 12th
November 12, 2009 15:49 ET
|
Angeles Chorale
LOS ANGELES, CA--(Marketwire - November 12, 2009) - The Angeles Chorale, a world-class, large
choral ensemble based in Los Angeles, led by world-renowned Resident Guest
Conductor Donald Neuen, will...
Attention: Planning Editors -- 2009 Vahagn Setian Charitable Foundation to Honor Carolina Liar and Host Student Fashion Show
April 29, 2009 17:52 ET
|
Vahagn Setian Charitable Foundation
BEVERLY HILLS, CA--(Marketwire - April 29, 2009) - Beverly Hills High School will be the
scene for the 2009 Vahagn Setian Charitable Foundation Special Event
honoring the memory of Vahagn Setian, a...
Vyteris and Zealand Pharma Announce Agreement on Active Transdermal Patch for Peptide Drugs
April 14, 2009 08:00 ET
|
Vyteris, Inc.
FAIR LAWN, NJ--(Marketwire - April 14, 2009) - Vyteris, Inc. (OTCBB: VYTR), developer of the
first FDA-approved active transdermal drug delivery system and a leader in
active transdermal drug...
Vyteris Announces Agreement for Additional Funding
March 25, 2009 08:00 ET
|
Vyteris, Inc.
FAIR LAWN, NJ--(Marketwire - March 25, 2009) - Vyteris, Inc. (OTCBB: VYTR), developer of the
first FDA-approved active transdermal drug delivery system and a leader in
active transdermal drug...
Vyteris Initiates Phase II Clinical Trial of Infertility Treatment Using Smart Patch Technology
March 10, 2009 08:00 ET
|
Vyteris, Inc.
FAIR LAWN, NJ--(Marketwire - March 10, 2009) - Vyteris, Inc. (OTCBB: VYTR), manufacturer of
the first FDA-approved active transdermal drug delivery system and a leader
in active transdermal drug...
Nobel Prize Laureate Dr. Peter Agre Awarded With the "Annual Prize for Outstanding Contribution to Lung Research" by Will Rogers Institute
December 11, 2008 18:42 ET
|
Will Rogers Institute
BEVERLY HILLS, CA--(Marketwire - December 11, 2008) - Nobel laureate Dr. Peter Agre was awarded
the "Annual Prize for Outstanding Contribution to Lung Research" at the
annual meeting for the Will...
T-A Health Education Center Announces Advisory Board Members
October 16, 2008 09:00 ET
|
T-A Health Education Center
BUFFALO, WY--(Marketwire - October 16, 2008) - The newly launched T-A Health Education Center
today announced the members of its advisory board, who will guide and
support the T-A Health Education...